chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My son has Autism. He started experiencing these symptoms shortly after his Vaccinations on March 23, 2007.  He stopped talking, singing, dancing, stopped making eye contact, stopped playing with his sisters and peers, he started flapping his arms and turning in circles all the time. He became deathly afraid of his bathtime. Before his vaccinations he loved his bathtime. He became obsessed with hair and started pulling out my hair and his sisters hair and then flossing with it. He pulls his own hair. He is getting hearing and speech evaluations. He is attending therapy at a Autism Institute.  04/15/2008 MR received from PCP for 15 month WCC 3/23/2007 and 2 yr WCC 4/01/08. Normal development noted at 15 month check.  All milestones met except unable to point to body parts.  At 2 yr WCC developmental abnormalities noted; no talking, unresponsive to voices, doesn't interact with others, hand wringing, running in circles, throwing things and does not point to objects. C/w Autism.  Refered for eval. My son stopped talking after receiving these vaccines (listed above on 3/23/2007). (He was saying 15-30 words adn 2-3 word sentenced prior to vaccines). He stopped responding to us or anybody else. He stopped responding to verbal comands. He became afraid of his bath time (which he used to love, same when we go to the pool, he is scared, used to love it). He developed transition problems. He is scared of loud noised example toilet flushing, hand drying machines in public rest rooms. Has been observed and the results put him at a level of the youngest a 3-6 month old and the oldest a nine month old. My son stims on an everyday basis. My husband and myself watched our son's slate get wiped dry after his vaccination on 3-23-07. Everyday is a struggle for our son. It is very frustrating for him not to be able to talk especially when he used to talk. To tell us what he needs or wants is a frustrating challenge for him and us. I can't go anywhere unless I have my husband (or another adult) with me to help with my son so that my 3 other children will be supervised also. I can't even go outside with my children unless another adult is present because autistic children have no sense of danger and will just take off and could run into the street. Going to church is a struggle. Once my son turns 3 he will not have a nursery to go to at the church and he is unable to sit in one place for that long. My son's autism effects his life and his families life daily. There is no cure, he will not recover. The damage has been done.
No symptoms after the injection until 15 days later of March 26. I noticed after getting in bed my arm felt hard, modernity warm,  medium pink, and  sore  in that area .  I had no fever, no aches or pains . Todays is 3/28/21 and is seems better as far as symptoms . I am due for the next shot on April 9. Should I still get the shot if in injections site is the same as it is right now?
PT PRESENTS WIH SKIN IRRITATION AND RED SPOTS ALL OVER BODY SINCE 25 APR 2009 PT SEEN PROVIDER ON 26 SPR 2009. PT ALSO STATED HE RECEIVED LORTAB 7.5, IBUPROFEN 800MG, AND AMOXIL FOR 7 DAYS BY DENTAL SECTION.  PT FIRST NOTED RASH ON WRIST AND HAS SPREADING.  NO FEVER, CHILLS, SWEATS AND HEADACHE.  ONSET OF A SORE THROAT, "NOT BAD ", THAT MORNING  RECEIVED SMALLPOX INOCULATION ON OR ABOUT 15 APRIL 2009.  PT WAS ISSUED HYDROXYZINE 25 MG AND MEDROL 4 MG.
I felt decent; just some sore muscles and where I was injected up until about 2 pm the day after the 2nd vaccine.  Then all of my muscles began to ache badly & by 4 pm I was suffering from on and off chills/ sweating ; this lasted all evening.  I checked my temperature & only once was the temperature above 100F.   I did have some chest pain at times as well.   I drank mint tea, took tylenol at regular intervals & used icy hot on the sore back and neck.    Following morning I'm feeling a little better but still quite a bit of soreness but as of 7 am , the chills/hots have subsided.  I did pee a lot over night; at one point I went to the bathroom about 5-6 times within an hour to 90 minutes.
Hospitalized 01/26/2022; COVID-19 positive 01/21/2022 (per d/c summary, no documentation found); fully vaccinated  Discharge Provider:  DO  Primary Care Provider : PA-C    Admission Date: 1/26/2022 Discharge Date: 02/01/2022  Hospital Course: Patient is a 73 y.o. female with PMHx of COPD 3L-dep baseline, hypothyroidism, depression with anxiety, chronic pain with neuropathy, history of left breast cancer who presented to ER with complaints of worsening shortness of breath with with other COVID sx going on for the previous 7-8 days. On January 21st she was tested positive for COVID-19.  Patient was vaccinated x2 last dose April of 2021. In the ED, she was hypoxic on her baseline 3 L and increased on her home O2. Chest x-ray shows mild atelectasis and developing infiltrate in the right base. She was started on Decadron and given fluids. Patient was admitted for acute on chronic hypoxic respiratory failure due to Pneumonia due to COVID-19 virus. In the hospital, patient was continued on steroids and started on lasix. UA was also found to be positive and patient was treated with macrobid then switched to rocephin for 5 days. She was weaned back to 3-4L NC was discharged home with services and to complete 3 more days of steroid for a total course of 10 days of decadron
Within 48 hours, patient developed left sided facial numbness, weakness of the left face (forehead, eyebrows, L eyelid, cheeks and corner of the mouth). Patient was seen on 4/25 and diagnosed with Bell's Palsy and started on Prednisone.
190 patients (9 different lot numbers) received a vaccine past the beyond used by date; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided      For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date).    This case was created for 119th of the 190 patients involved. Concomitant medication was not provided. It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 Vaccine. Treatment information was not reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-704335 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704335:MASTER CASE
The patient stated that recently tested positive for COVID (coronavirus disease) and had lost his sense of smell.; tested positive for COVID; inappropriate schedule of vaccine administered; inappropriate schedule of vaccine administered; This is a spontaneous report from a contactable consumer based on information received by Pfizer. A 46-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration on 27Apr2021 (Batch/Lot number was not reported) as DOSE 2, SINGLE and dose 1 via an unspecified route of administration on 16Apr2021 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included ongoing psoriasis. Concomitant medication included etanercept (ENBREL) taken for Plaque psoriasis 50 milligram, weekly on an unknown start date and stopped in Apr2021 and again started on an unspecified date in 2021. In 2021, the patient experienced the patient stated that recently tested positive for covid (coronavirus disease) and had lost his sense of smell, tested positive for covid, inappropriate schedule of vaccine administered. The patient underwent lab tests and procedures which included sars-cov-2 test: positive in 2021. The outcome of event was unknown.  No follow-up attempts are possible. No further information is expected.
have real sharp pain under left breast; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 10Mar2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for Covid-19 immunisation. The following information was reported: BREAST PAIN (non-serious), outcome "unknown", described as "have real sharp pain under left breast".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
About a week after I began getting a large red rash around the vaccine site, about 1- 1 1/2 inches. It was really itchy. I sent a telehealth message to my Provider who advised me to take a over the counter antihistamine and apply ice for the itching. It went away after 2-3 doses of the antihistamine.
Redness down arm stopping at the elbow. Warm to the touch. Pt C/O itching and mild discomfort. No medications used to alleviate any of the symptoms.
Starting 12/23/2022, I woke up feeling like I was coming down with something. I decided to test myself for COVID-19 and I was positive. I took my temperature which was 99 and I felt tired with a mild headache and sore throat. I called the doctor that day and they prescribed PAXLOVID. I started taking it that day. I was tired for 2-3 days and yesterday I actually went on the exercise bike but was sweating a lot (which is unusual). My voice is slightly raspy but otherwise I'm okay. Tomorrow morning will be the last dose I take of the PAXLOVID. I am feeling almost completely better. Thursday, 12/29/2022, I will go get a PCR test which was requested by my doctor and then on Saturday, 12/31/2022, I will take the at-home COVID-19 test to make sure I'm clear.
PER PT, RECEIVED PREVNAR 13 ON 1/14/15. WOKE UP 1/15/15 WITH MODERATE LEFT DELTOID PAIN (LIKE HE GOT PUNCHED IN ARM), GENERALIZED MUSCLE & JOINT ACHES WORSE IN LEFT ARM. TEMP = 99.7. + COUGH AND HEADACHE, 4 X 2 INCH SWELLING AT INJECTION SITE. ALL SYMPTOMS IMPROVED TODAY BY ABOUT 80% EXCEPT INJECTION SITE SWELLING.
Received the 2nd shot on March 16th.  On March 17th, I had a large red spot around the spot I got the shot, quarter size lump, arm hurt and that night I got the chills.  Then on the 18th I had still have large red spot on the arm, arm pain, small lump, chills, very tired, and slightly blurry.   Then on the 19th I still have the large red spot on the arm about the size of 3-4" dia.  I was nauseous later that night but not sure from shot or something I ate?   On Saturday and Sunday (March 20th & 21st), arm stop hurting but still large red spot about silver dollar size.  Today (March 22nd) the spot is pink, and reduce to about 1/2 dollar size.
Adverse Event: Intense achy pain near left armpit Treatment: Moist heating pad Outcome: Pain lessened; 20 minutes x2 with heating pad
Mother called health department. Stated child received varicella and MMR vaccines at doctors office on 09/20/2001. Starting 09/27/2001 or 09/28/2001, child had high fever 102.9. Starting this morning the fever is down, but the child has rash on face "like acne" and trunk like "heat rash".
the day of vaccine I got bumps on arm it  looked like pimples full off water or some substance. Then I started loosing alot of weight no appetite and started will full blown seizures.
significant rash on chest wall, itches, no sob or wheezing treated with kenalog cream
This spontaneous report as received from a pharmacist refers to a 57 year old male patient. The patient had no drug reactions or allergies. on 30-OCT-2013 the patient was vaccinated with ZOSTAVAX (subcutaneous in the left arm, 0.65 ml, lot # J006828 EXP 14-SEP-2014) for prevention of shingles. Concomitant therapies included "flu shot" (manufacturer unknown) (received on 23-OCT-2013). On 30-OCT-2013, the patient experienced redness, about "fist size", on the left posterior bicep, around injection site, which was warm to touch and uncomfortable. On 31-OCT-2013 the patient was treated with BENADRYL orally and used BENADRYL cream topically. Pharmacist reported that on 11-NOV-2013 the patient experienced "doesn't feel like he normally would". Pharmacist reported redness was varying degrees of red, which could be a rash. Patient was sent to see his physician on 01-NOV-2013. Pharmacist accepted VZVIP packet and VZVIP packet was faxed. The patient sought medical attention (saw a pharmacist) and received treatment. The outcome of the events was unknown. Additional information has been requested.
1/31/08 - developed left eye pain and excessive tearing.  2/2/08 - developed left facial droop and facial dystonia.  Diagnosed with Bell's Palsy by doctor and placed on Valtrex and Prednisone taper x 10 days and vitamin B complex supplements.
25JUN96 fever (low grade) has not taken w/thermometer but believes it is about 101-102;27JUN96 rash on face & few spots on body (back & legs);fussy, not sleeping for 2 noc;p/APAP given temp is relieved for 5hr & then return;seems achy;
7 year-old received Kinrix; This was the third Dtap on patient´s schedule.; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 7-year-old female patient who received DTPa-IPV (Kinrix) (batch number 2KL4K, expiry date 9th November 2023) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   Previously administered products included Dtap vaccine  (received 2 doses of Dtap series on an unknown date).   On 20th October 2022, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 20th October 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and inappropriate schedule of vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and inappropriate schedule of vaccine administered were unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 26-Oct-2022 Reporter's comment: The health care professional reported that this  kinrix shot was the third Dtap on the patient's vaccination schedule. The reporter consented to follow-up by email. Additional supportive information: The patient received Kinrix vaccine as third Dtap dose by error at inappropriate age, which led to inappropriate age at vaccine administration and inappropriate schedule of vaccine administered.
shingles; This spontaneous report was received from a lawyer regarding a case in litigation and referring to a female patient of unknown age. No information was provided regarding medical history, concurrent condition, or concomitant medication.  On an unknown date, the patient was vaccinated with zoster vaccine live(ZOSTAVAX) (lot#, expiration date, dose, dose number and route was not specified) for the long-term prevention of shingles and zoster-related conditions. On an unspecified date, the patient experienced shingles. On an unspecified date, the patient was treated by a healthcare provider for shingles. The outcome of the shingles was not reported. The reporter considered the shingles to be related to zoster vaccine live (ZOSTAVAX).  Additional information has been requested.
no adverse event; Improperly stored vaccines administered; This spontaneous report was received from other and refers to some patients. The patient's concurrent conditions, medical history and concomitant medications were not reported.   On 28-JUL-2023, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, 0.5 milliliter, three dose series, lot #W014513, expiration date: 26-JAN-2025, administered for prophylaxis (strength, and route of administration were not provided).   On 28-JUL-2023, 5 patients in total and additional patients were administered the affected hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) from the lot involved in a temperature excursion at the same location (Product storage error). No adverse events reported (No adverse event).   This is a non-valid case due to no patient's identifiers.   Follow up information has been received from an other health professional on 09-AUG-2023 and refers to a 11-year-old female patient. Concomitant medications included diphtheria vaccine toxoid (+) pertussis vaccine acellular (+) tetanus vaccine toxoid (TDAP) (lot # 213723, expiration date: 17-OCT-2025 via Right Deltoid) and meningococcal vaccine conj (lot # AMVA767A, expiration date: ??-DEC-2023 via Left Deltoid). The date of the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was 02-AUG-2023 via Left Deltoid.     This is one of several reports from same reporter. ; Sender's Comments:  US-009507513-2308USA001806: US-009507513-2309USA000748: US-009507513-2309USA000743: US-009507513-2309USA000744: US-009507513-2309USA000745: US-009507513-2309USA000746:
Sudden onset of rhinorrhea, cough, wheezing, SOB s/p vaccination with pneumococcal vaccine. Required O2.
This spontaneous report as received from a certified medical assistant refers to a 14 year old male patient. None pertinent medical history, drug reactions/allergies and concomitant medications were reported. On 23-MAY-2002, the patient was vaccinated with the first dose of (Oka/Merck) VARIVAX (dose, route of administration, expiration date and lot # were not reported). On 29-JUN-2010, the patient was vaccinated with the second dose of (Oka/Merck) VARIVAX (dose, route of administration, expiration date and lot # were not reported). On 04-AUG-2016, the patient developed shingles. The patient sought medical attention - he was seen in the physician's office and he received the treatment with VALTREX (1g 3 times a day). None lab diagnostics studies were performed. The outcome of shingles was reported as not recovered.  The relatedness between the adverse event and the vaccination with (Oka/Merck) VARIVAX was not reported. Additional information has been requested.
Information has been received from a licensed practical nurse referring to unspecified patients of unknown age and gender. On unspecified dates, the patients were vaccinated with VAQTA which had been exposed to temperatures outside of the recommended range, (lot # K005323, expiry date 10-FEB-2017; lot# K007827, expiry date 09-DEC-2016), (route, dose and frequency not reported). No adverse effect had been reported. This is one of several reports received from the same reporter. Additional information has been requested.
Information has been received from a physician concerning a 9 week old male with no pertinent medical history or drug allergies who on 04-JAN-2008 was vaccinated PO with his first 2.0 ml dose of Rotateq (lot# 657984/1169U).  Concomitant vaccinations administered on that same day included a dose of DAPTACEL, a dose of PEDVAXHIB (manufacturer unknown), a dose of PREVNAR and a dose of IPOL (Vero).  On 30-JAN-2008 the patient was admitted to the hospital for 5 days and was initially being worked up for sepsis.  It was noted that the patient did not have "typical intussusception symptoms."  The patient was lethargic, not eating well, and only vomited a small amount.  The patient appeared to be getting better.  On 01-FEB-2008 the patient experienced a bloody stool and was diagnosed with intussusception and underwent surgery for treatment.  Lab diagnostic studies included: abdominal ultrasound, air contrast enema, unspecified blood work, unspecified work up for sepsis, spinal tap and a chest X-ray.  When asked if the patient's experience was life-threatening she replied, "I guess so if not diagnosed).  A section of his bowel had to be removed."  Subsequently, the patient recovered.  There was no product quality complaint.  The physician considered intussusception to be disabling, life-threatening and an other important medical event (surgery).  Additional information has been requested.  4/18/08 Reviewed initial hospital medical records for 1/30-01/01/2008. TRANSFER DX: Intussusception, failed air enema reduction. Records reveal patient experienced lethargy, irritability, vomiting x1, diet refusal.  Exam revealed decreased tone & head lag.  Developed rectal bleeding 2/1 & was transferred emergently to higher level of care for peds surgical consult.   5/1/08 Reviewed hospital medical records for 2/1-2/5/2008. FINAL DX: intussusception w/small bowel obstruction; Meckel's diverticulum. Records reveal patient experienced hyperglycemia & lethargy.   Seen at outlying hospital & transferred w/US revealed IS unable to be reduced by air enema.  Repeat US confirmed IS & repeat air enema failed to reduce.  Taken to OR where findings included necrotic bowel, ileocolic IS & Meckel's diverticulum.  Admitted to PICU for post op hypotension managed w/fluids.  Progressed well, tolerated oral feeds & d/c to home w/additional f/u regarding hyper/hypoglycemic episodes.
On 11/3/15, 76 yo M presented to clinic for annual exam. During this visit, pt was ordered and administered Pneumococcal Conjugate 13-Valent (Prevnar 13) vaccine 0.5 mL in right deltoid (NDC #0005-1971-01, Lot #m13068, Exp: 4/1/2017). Pt tolerated injection without incident and was discharged home in stable condition. On 11/10, one week after the injection, pt called the clinic and reported that he may be having a site reaction to the pneumonia vaccine. Pt returned to clinic for exam and MD found a very faint papular rash present at the injection site which was mildly warm. MD stated "likely mild reaction to Prevnar". Pt was advised to use Claritin (loratadine) and ice to the area as needed. Pt was discharged home with these instructions.
The pt experienced redness, swelling to right deltoid. Also experienced warmth and pain to touch.
Pain at injection site that was progressing to different areas of the arm.  Patient was instructed on 10/20 to monitor, ice, and use over-the-counter pain relievers from the pharmacist who administered the vaccine.  Another call was made on 10/24 with symptoms persisting, and the call was connected to patient's primary care provider for additional instruction.
Patient came home very combative with wife who reported adverse event. Patient was "white faced" and complained of upset stomach. Pt symptoms have improved since then but still complaining of upset stomach.
Pt recv vax in 3/97; in 8/97 pt exp hair loss; tx=Temovate gel w/ no success